IX-01

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameIX-01
Drug Alias NameIX-01
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOxytocin receptor antagonists
TargetsOxytocin receptor
Therapy Area/IndicationsPremature Ejaculation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIxchelsis Ltd
Active IndicationsN/A
Inactive IndicationsPremature Ejaculation

Other Information

ATC CodeN/A
Related LinksN/A